(Q43250303)

17 November 2017

title

Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma (English)

1 reference

17 November 2017

0 references

Ross D Brown

1

1 reference

17 November 2017

Andrew Spencer

2

1 reference

17 November 2017

Phoebe Joy Ho

3

1 reference

17 November 2017

Nola Kennedy

4

1 reference

17 November 2017

Karieshma Kabani

5

1 reference

17 November 2017

Shihong Yang

6

1 reference

17 November 2017

Daniel M Sze

7

1 reference

17 November 2017

Esther Aklilu

8

1 reference

17 November 2017

John Gibson

9

1 reference

17 November 2017

Douglas E Joshua

10

1 reference

17 November 2017

publication date

1 November 2009

1 reference

17 November 2017

1 reference

17 November 2017

volume

50

1 reference

17 November 2017

issue

11

1 reference

17 November 2017

page(s)

1860-1864

1 reference

Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428190903216804

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903216804

Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903216804

Immunomodulatory drug costimulates T cells via the B7-CD28 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903216804

The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903216804

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903216804

Clonal cytotoxic T cells in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903216804

Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903216804

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903216804

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903216804

Effect of Thalidomide on the Graft versus Host Reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190903216804

10.3109/10428190903216804

21 January 2018

Identifiers

DOI

1 reference

17 November 2017

1 reference